BERKSHIRE AESTHETICS LTD

🌳Matureactive
07975957 · ltd · incorporated 2012-03-05
Investment thesis
Well-run mature business — low negotiation leverage; premium likely.
Why interesting: Textbook target; clean filings, stable trading.
Why risky: No pressure on seller; any deal likely at full price.
Opportunity decay
approaching window · 12-months
Approaching a transaction window — refinance or sale event plausible in the next 12 months.
  • · Oldest live charge 6.4y old — refinance window within 12 months
🔒Estimated value
Upgrade to see
Turnover
year to Sept 2024
Net worth
£819.0k
book net assets
Opportunity
75/100
Strong
🔔
Follow this company (free)
Email alerts on filings, charges, director changes, gazette notices. No account needed.

Unsubscribe any time from any email. GDPR-respectful.

What this business does
Primary activity: Specialist medical practice activities
Sector: Human health & social work
Investor take
Pursue
Strong opportunity: active trading company with strong profile and bankable structure.

Opportunity 75/100 (strong), bankability 80/100. High owner-dependency — earn-out structure likely required for clean transition. Share purchase looks the cleaner deal structure. Most likely exit: strategic trade sale (65/100).

🏦

Refinance opportunity

1 live charge · oldest 6.4y

85/100
ready

Refinance conversation should be productive — structure clean and timing right.

  • · Oldest live charge is 6.4 years old — likely at or near maturity.
  • · Single lender — cleanest path to refinance.
  • · Legal-friction score 15/100 — clean.

Data confidence

Overall: high (83/100)

Strong data coverage across all sections. AI outputs should be trusted with minimal caveats.

Company profile
address, 1 SIC codes, incorporation date
100
Financials
2 years of iXBRL accounts extracted (YoY deltas available) + narrative notes parsed
75
Lenders & charges
1 charges (1/1 with lender, 1/1 with type)
90
Directors & officers
2 officers (2 active, 2 linked, 2 with DOB)
90
Ownership & PSC
1 active PSC(s) of 3 total, 3 with control declared
90
Director network
12 connected companies via shared directors
81
Filing history
42 filings on record
85
Gazette notices
No matching gazette notices (standard for active companies)
60
Opportunity Score
75/100Strong
PassWatchWorth a lookStrongExceptional 

Solid opportunity signal. Worth a dedicated memo and management meeting.

Business quality
70
Active, clean filings, stable charge profile.
Acquirability
55
Some acquirability indicators.
Risk profile
85
Few red flags.
Signal strength
100
Good data coverage for analysis.

Signals from accounts

Derived from iXBRL accounts · FRS 102
Positive net assets
Net assets £819,022
Net assets shrinking
Down £195,139 YoY
Cash YoY
+25%
Year on year

Key financials

2 years extracted from filed iXBRL accounts
Cash
£414k
↑ 25% YoY
Net Worth
£819k
↓ 19% YoY
Current Assets
£867k
↑ 11% YoY
Current Liabilities
£0£203k£406k£608k£811k£1.0mSept 2023Sept 2024

Hover to see exact values · click legend to toggle series

Financials

Extracted from Companies House accounts · FRS 102
Metric2024-09-302023-09-30
Total assets£846.6k£1.03M
Current assets£867.0k£784.1k
Cash£414.4k£332.3k
Debtors£352.3k£351.6k
Net assets£819.0k£1.01M

Amounts extracted automatically from iXBRL. Fields left blank were not reported or not mapped. Values in GBP unless stated.

Recent activity

Last 30 days
0
filings
Last 90 days
0
filings
Last 180 days
1
filing
  • 1 confirmation-statement
Counts from Companies House filing history.
Corporate timeline (20 events)Click to expand
  1. 2025-10-28
    📄
    change-person-director-company-with-change-date
    officers · CH01
  2. 2025-10-14
    📄
    change-person-director-company-with-change-date
    officers · CH01
  3. 2025-09-27
    📄
    accounts-with-accounts-type-unaudited-abridged
    accounts · AA
  4. 2024-09-30
    📄
    accounts-with-accounts-type-unaudited-abridged
    accounts · AA
  5. 2023-10-27
    📄
    capital-name-of-class-of-shares
    capital · SH08
  6. 2023-10-16
    📄
    notification-of-a-person-with-significant-control
    persons-with-significant-control · PSC02
  7. 2023-10-16
    📄
    cessation-of-a-person-with-significant-control
    persons-with-significant-control · PSC07
  8. 2023-10-16
    📄
    cessation-of-a-person-with-significant-control
    persons-with-significant-control · PSC07
  9. 2023-09-30
    📄
    accounts-with-accounts-type-unaudited-abridged
    accounts · AA
  10. 2022-09-28
    📄
    accounts-with-accounts-type-unaudited-abridged
    accounts · AA
  11. 2021-09-30
    📄
    accounts-with-accounts-type-unaudited-abridged
    accounts · AA
  12. 2021-02-27
    📍
    change-registered-office-address-company-with-date-old-address-new-address
    address · AD01
  13. 2020-10-31
    📄
    accounts-with-accounts-type-micro-entity
    accounts · AA
  14. 2020-01-28
    📄
    mortgage-create-with-deed-with-charge-number-charge-creation-date
    mortgage · MR01
  15. 2020-01-23
    🔒
    Charge registered #1
    Lender: Barclays Security Trustee Limited
  16. 2019-06-30
    📄
    accounts-with-accounts-type-micro-entity
    accounts · AA
  17. 2018-12-28
    📄
    change-account-reference-date-company-previous-extended
    accounts · AA01
  18. 2016-04-18
    LANGDON, Selena Kaur, Dr appointed
    director
  19. 2012-03-05
    🏢
    Company incorporated
    As BERKSHIRE AESTHETICS LTD
  20. 2012-03-05
    LANGDON, Peter Michael appointed
    director

Owner dependency

71/100
High — earn-out structure required

Material founder dependency. Consider a 2-3 year earn-out and build in a handover plan before completion.

FACTORS
  • +Two-director setup: Only two active directors — typical of owner-managed SMEs but limits succession.
  • +Family involvement: Multiple officers share a surname — likely family business, which concentrates governance.
  • +No director turnover: Company is 14 years old with no director changes — suggests a very tight-knit founder team never broadened.

Succession & seller-readiness

49/100
Moderate signal

Some succession indicators present. Worth watching; approach if sector/strategy fits.

SIGNALS
  • secondaryTwo-director governance: Small-team governance. Succession depth is thin but not absent.
  • secondary12+ year tenure: Director in role 14 years.
  • supportingClean filings + long tenure: Disciplined long-tenure operator — classic lifestyle-business pattern that often sells quietly.

Red flags

clean
No red flags detected from available public data. (This is not a clean bill of health — detailed accounts review still recommended.)

Group structure

Aesthetic Holdings Limited is the ultimate parent — holding 75%+ shares. This company sits inside their group.

🏛️
Aesthetic Holdings Limited
Corporate parent · holds 75-100% shares · board control
ultimate parent
BERKSHIRE AESTHETICS LTD
This company · 07975957

Parent relationships inferred from Persons with Significant Control filings. Full subsidiary tree requires reverse-lookup (coming).

Shareholders & ownership

1 active beneficial owner · dominant holder ≥75%
NameSharesVoting rightsNature of controlNotified
Aesthetic Holdings Limited
Corporate entity
75100%
75–100%board control75-100% shares · 75-100% voting · board control26/06/2023
2 historic (ceased) PSCs
  • Dr Selena Kaur Langdonceased 26/06/2023· 25-50% shares
  • Mr Peter Michael Langdonceased 26/06/2023· 25-50% shares

From Companies House Persons with Significant Control filings. Share ranges are banded per the public PSC regime.

🔒Co-director network graph

Radial SVG graph showing every company connected via shared directors, colour-coded by status.

Available from the Pro tier upwards.

See pricing →

Similar companies

Active · Healthcare & medical · SL postcode area
CompanyEst. valueTurnoverNet worthStaffAgeOppDirector
A. I ANAESTHETIC LTD
14146378 · est 2022 · no financials extracted
3y
A1 CARING BEES LTD
14732030 · est 2023 · no financials extracted
3y
AADIYA LIMITED
14599421 · est 2023 · no financials extracted
3y
ABBEY D. SURGERY LTD
06544621 · est 2008 · no financials extracted
18y
ABSOLUTE OPTICS LTD
11741564 · est 2018 · no financials extracted
7y
ACE LOCUMS LIMITED
03105144 · est 1995 · no financials extracted
30y
ACNESTIS LIMITED
11648018 · est 2018 · no financials extracted
7y
ADIVTA LIMITED
14761448 · est 2023 · no financials extracted
3y
ADOMNHYIRA CO. LIMITED
11952910 · est 2019 · no financials extracted
6y
ADVANCED FACIAL SURGERY LIMITED
08696054 · est 2013 · no financials extracted
12y
ADVANCED SURGICAL SERVICES LTD
16895316 · est 2025 · no financials extracted
AETAS PRIME LTD
14645574 · est 2023 · no financials extracted
3y
Peers ranked by estimated value, then turnover, then opportunity score.See all →
🔒Tailored diligence questions

6 specific questions generated from this company's actual signals — liquidity, leverage, director age, charge count, red flags, age-of-company.

Available from the Pro tier upwards.

See pricing →
🔒Advanced scoring suite

Exit-route ranking, improvement thesis, quiet-distress detector, covenant-pressure proxy, extraction monitor, approaching triggers, ownership drift, local cluster, value trap, debt capacity, archetype classification — 48+ scoring modules.

Available from the Pro tier upwards.

See pricing →

Company details

Statusactive
Typeltd
Incorporated2012-03-05
Jurisdictionengland-wales
Primary SIC86220 — Specialist medical practice activities

Registered office

Berkshire Aesthetics
Furze Platt Road
Maidenhead
SL6 6PR
England

Filing status

Accounts
Next due: 2026-06-30
Last made up to: 2024-09-30
Confirmation statement
Next due: 2027-03-13
Last: 2026-02-27

Officers (2 active · 0 resigned)

LANGDON, Peter Michael
director · ~47y · appointed 2012-03-05
View their other companies + combined net worth →
Active
LANGDON, Selena Kaur, Dr
director · ~44y · appointed 2016-04-18
View their other companies + combined net worth →
Active

Click a director name to see their full track record across all companies.

Mortgages & charges

1
Total charges
1
Outstanding
1
Active lenders
Status:Lender:1 of 1 shown
TypeProperties
outstanding
Barclays
Barclays Security Trustee Limited
A registered charge23/01/2020
Click column headers to sort. Use filters above to narrow by status and lender.

Recent filings (42 total)

confirmation-statement-with-no-updates
confirmation-statement · CS01
2026-03-08
change-person-director-company-with-change-date
officers · CH01
2025-10-28
change-person-director-company-with-change-date
officers · CH01
2025-10-14
accounts-with-accounts-type-unaudited-abridged
accounts · AA
2025-09-27
confirmation-statement-with-no-updates
confirmation-statement · CS01
2025-03-06
accounts-with-accounts-type-unaudited-abridged
accounts · AA
2024-09-30
confirmation-statement-with-updates
confirmation-statement · CS01
2024-02-27
capital-name-of-class-of-shares
capital · SH08
2023-10-27
notification-of-a-person-with-significant-control
persons-with-significant-control · PSC02
2023-10-16
cessation-of-a-person-with-significant-control
persons-with-significant-control · PSC07
2023-10-16
cessation-of-a-person-with-significant-control
persons-with-significant-control · PSC07
2023-10-16
accounts-with-accounts-type-unaudited-abridged
accounts · AA
2023-09-30
confirmation-statement-with-no-updates
confirmation-statement · CS01
2023-02-27
accounts-with-accounts-type-unaudited-abridged
accounts · AA
2022-09-28
confirmation-statement-with-no-updates
confirmation-statement · CS01
2022-03-10